Form EFFECT ReShape Lifesciences
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 20, 2025 |
| Accession Number: | 0001104659-25-060003 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- David Meltzer Delivers Inspiring Zeigler University Guest Speaker Series Presentation On Building A Culture of Champions
- Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules
- SeAH Besteel Becomes First in Korea to Secure Technologies for Two Core Hydrogen Infrastructure Materials
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
